|
|
|
|
|
| (11) | Liudijimo numeris | C 2906298 |
| (68) | Patento numeris | 2906298 |
| (21) | Paraiškos papildomos apsaugos liudijimui gauti numeris | PA 2023 516 |
| (22) | Paraiškos papildomos apsaugos liudijimui gauti padavimo data | 2023-05-09 |
| (41) | Paraiškos papildomos apsaugos liudijimui gauti paskelbimo data | 2023-05-25 |
| Liudijimo paskelbimo data | 2025-04-25 | |
| (24) | Liudijimo įsigaliojimo data | 2033-10-12 |
| (71) |
Medimmune Limited,
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH,
GB
ADC Therapeutics SA, Route de la Corniche 3B, 1066 Epalinges, CH |
| (73) |
Medimmune Limited,
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH,
GB
ADC Therapeutics SA, Route de la Corniche 3B, 1066 Epalinges, CH |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/22/1695, 2022-12-20 |
| (94) | 2037-12-22 |
| (95) | Lonkastuksimabo tesirinas, bet kokia forma apsaugotas pagrindinio patento |
| PAL išduotas |